Effect of a casbane diterpene isolated from Croton nepetaefolius on the prevention and control of biofilms formed by bacteria and Candida species

Industrial Crops and Products

Volumn 61, Issue , 2014, Pages 499-509

  Vasconcelos, Mayron A ^a,b   Arruda, Francisco V S ^a   Santos, Hélcio S ^c   Rodrigues, Adriano S ^c   Bandeira, Paulo N ^c   Albuquerque, Maria R J R ^c   Cavada, Benildo S ^a   Teixeira, Edson H ^a   Henriques, Mariana ^b   Pereira, Maria O ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSIDADE ESTADUAL VALE DO ACARAÚ   (Brazil)

Author keywords

Bacteria; Biofilm; Candida; Casbane diterpene; Polymicrobial infections

Indexed keywords

ANTIMICROBIAL AGENTS; BIOFILMS; CANDIDA; OLEFINS; YEAST;

BIOFILM FORMATION; CANDIDA ALBICANS; CANDIDA GLABRATA; DITERPENES; MINIMUM INHIBITORY CONCENTRATION; POLYMICROBIAL INFECTIONS; PREVENTION AND CONTROLS; PSEUDOMONAS AERUGINOSA; CANDIDA SPECIES;

BACTERIA;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOFILM; CONCENTRATION (COMPOSITION); DICOTYLEDON; FUNGUS; INHIBITOR; TERPENE; MICROBIAL ACTIVITY; PERFORMANCE ASSESSMENT; PLANT EXTRACT; YEAST;

CANDIDA; CROTON NEPETAEFOLIUS;

EID: 84907321224     PISSN: 09266690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.indcrop.2014.07.027     Document Type: Article

References (43)

1. Bandara H.M., Yau J.Y.Y., Watt R.M., Samaranayake L.P. Research article Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development. BMC Microbiol. 2010, 10:125.
2. Bonnin A. The commensal-pathogen transition in invasive Candida albicans infection: molecular and cellular approaches. Bull. Acad. Natl. Med. 2012, 196:139-149.
3. Carlson E., Johnson G. Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice. Infect. Immun. 1985, 50:655-659.
4. Carlson E. Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity. Infect. Immun. 1983, 42:285-292.
5. Carlson E. Synergism of Candida albicans and delta toxin producing Staphylococcus aureus on mouse mortality and morbidity: protection by indomethacin. Zentralbl. Bakteriol. Mikrobiol. Hyg. 1988, 269:377-386.
6. Carneiro V.A., Santos H.S., Arruda F.V.S., Bandeira P.N., Albuquerque M.R.J.R., Pereira M.O., Henriques M., Cavada B.S., Teixeira E.H. Casbane diterpene as a promising natural agent against biofilm-associated infections. Molecules 2011, 16:190-201.
7. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
8. Douglas L.J. Medical importance of biofilms in Candida infections. Ver. Iberoam. Micol. 2002, 19:139-143.
9. Elias S., Banin E. Multi-species biofilms: living with friendly neighbors. FEMS Microbiol. Rev. 2012, 36:990-1004.
10. Evans S.A., Turner S.M., Bosch B.J., Hardy C.C., Woodhead M.A. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur. Respir. J. 1996, 9:1601-1604.
11. Gibson J., Sood A., Hogan D.A. Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative. Appl. Environ. Microbiol. 2009, 75:504-513.
12. Grillot R., Portmann-Coffin V., Ambroise-Thomas P. Growth inhibition of pathogenic yeasts by Pseudomonas aeruginosa in-vitro: clinical implications in blood cultures. Mycoses 1994, 37:343-347.
13. Gupta N., Haque A., Mukhopadhyay G., Narayan R.P., Prasad R. Interactions between bacteria and Candida in the burn wound. Burns 2005, 31:375-378.
14. Habibi Z., Eftekhar F., Samiee K., Rustaiyan A. Structure and antibacterial activity of a new labdane diterpenoid from Salvia leriaefolia. J. Nat. Prod. 2000, 63:270-271.
15. Hammer K.A., Carson C.F., Riley T.V. Malaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Med. Mycol. 2000, 38:355-362.
16. Hogan D.A., Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 2002, 296:2229-2232.
17. Høiby N. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med. 2011, 9:32.
18. Høiby N., Bjarnsholt T., Givskov M., Molin S., Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 2010, 35:322-332.
19. Holcombe L.J., McAlester G., Munro C.A., Enjalbert B., Brown A.J., Gow N.A., Ding C., Butler G., O'Gara F., Morrissey J.P. Pseudomonas aeruginosa secreted factors impair biofilm development in Candida albicans. Microbiology 2010, 156:1476-1486.
20. Kett D.H., Azoulay E., Echeverria P.M., Vincent J.L. Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit. Care Med. 2011, 39:665-670.
21. Klotz S.A., Gaur N.K., De Armond R., Sheppard D., Khardori N., Edwards J.E., Lipke P.N., El-Azizi M. Candida albicans Als proteins mediate aggregation with bacteria and yeasts. Med. Mycol. 2007, 45:363-370.
22. McAlester G., O'Gara F., Morrissey J.P. Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. J. Med. Microbiol. 2008, 57:563-569.
23. Mendoza L., Tapia L., Wilkens M., Urzúa A. Antibacterial activity of 13-epi- sclareol, a labdane type diterpene isolated from Pseudognaphalium heterotrichium and P. cheiranthifolium (Asteraceae). Bol. Soc. Chil. Quím. 2002, 47:91-98.
24. Morales D.K., Hogan D.A. Candida albicans interactions with bacteria in the context of human health and disease. PLoS Pathog. 2010, 6:e1000886.
25. Murphy C.N., Clegg S. Klebsiella pneumoniae and type 3 fimbriae: nosocomial infection, regulation and biofilm formation. Fut. Microbiol. 2013, 7:991-1002.
26. Peleg A.Y., Hogan D.A., Mylonakis E. Medically important bacterial-fungal interactions. Nat. Rev. Microbiol. 2010, 8:340-349.
27. Peters B.M., Jabra-Rizk M.A., Scheper M.A., Leid J.G., Costerton J.W., Shirtliff M.E. Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol. Med. Microbiol. 2010, 59:493-503.
28. Ramage G., Tomsett K., Wickes B.L., Lopez-Ribot J.L., Redding S.W. Denture stomatitis: a role for Candida biofilms. Oral Surg. Oral Med. 2004, 98:53-59.
29. Sá N.C., Cavalcante T.T., Araújo A.X., Dos Santos H.S., Albuquerque M.R., Bandeira P.N., Da Cunha R.M., Cavada B.S., Teixeira E.H. Antimicrobial and antibiofilm action of casbane diterpene from Croton nepetaefolius against oral bacteria. Arch. Oral Biol. 2012, 57:550-555.
30. Samaranayake Y.H., Ye J., Yau J.Y., Cheung B.P., Samara-nayake L.P. In vitro method to study antifungal perfusion in Candida biofilms. J. Clin. Microbiol. 2005, 43:818-825.
31. Santos H.S., Mesquita F.M.R., Lemos T.L.G., Monte F.J.Q., Braz-Filho R. Diterpenos casbanos e acetofenonas de Croton nepetaefolius (Euphorbiaceae). Quim Nova 2008, 31:601-604.
32. Schachter B. Slimy business - the biotechnology of biofilms. Nat. Biotechnol. 2003, 21:361-365.
33. Seneviratne C.J., Silva W.J., Jin L.J., Samaranayake Y.H., Samaranayake L.P. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch. Oral Biol. 2009, 54:1052-1060.
34. Shirtliff M.E., Peters B.M., Jabra-Rizk M.A. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett. 2009, 299:1-8.
35. Silva S., Negri M., Henriques M., Oliveira R., Williams D.W., Azeredo J. Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol. 2011, 19:241-247.
36. Stepanovic S., Vukovic D., Dakic I., Savic B., Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 2000, 40:175-179.
37. Timsit J.F., Cheval C., Gachot B., Bruneel F., Wolff M., Carlet J., Regnier B. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med. 2001, 27:640-647.
38. Urzúa A., Caroli M., Vasquez L., Mendoza L., Wilkens M., Tojo E. Antimicrobial study of the resinous exudate and of diterpenoids isolated from Eupatorium salvia (Asteraceae). J. Ethnopharm. 1998, 62:251-254.
39. Urzúa A., Jara F., Tojo E., Wilkens M., Mendoza L., Rezende M.C. A new antibacterial clerodane diterpenoid from the resinous exudates of Haplopappus uncinatus. J. Ethnopharm. 2006, 103:297-301.
40. Urzúa A., Rezende M.C., Mascayano C., Vásquez L. A structure-activity study of antibacterial diterpenoids. Molecules 2008, 13:882-891.
41. Valenza G., Tappe D., Turnwald D., Frosch M., König C., Hebestreit H., Abele-Horn M. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J. Cyst. Fibros. 2008, 7:123-127.
42. Velikova M., Bankova V., Marcucci M.C., Tsvetkova I., Kujumgiev A. Chemical composition and biological activity of propolis from Brazilian meliponinae. Z. Naturforsch. 2000, 55:785-789.
43. Williams P., Cámara M. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr. Opin. Microbiol. 2009, 12:182-191.